State of Cancer Control in Rwanda: Past, Present, and Future Opportunities

Area of Science:

• Oncology
• Public Health
• Health Policy

Background:

• Rwanda, a low-income East African nation, has achieved significant development post-1994 genocide.
• Healthcare delivery relies on public hospitals, with private sector growth and over 80% community-based health insurance coverage (Mutuelle de Santé).
• The Rwanda Biomedical Center's cancer unit leads national cancer control policy and implementation.

Purpose of the Study:

• To outline the progress and challenges in cancer control within Rwanda.
• To highlight recent advancements in cancer treatment infrastructure and policy.
• To identify areas requiring further development for comprehensive cancer care.

Main Methods:

• Review of national cancer control initiatives and policy implementation.
• Assessment of healthcare infrastructure for cancer treatment, including chemotherapy and radiotherapy.
• Analysis of progress in vaccination programs, cancer registries, and research activities.

Main Results:

• Rwanda has launched a 5-year National Cancer Control Plan and strengthened its cancer registry.
• New facilities, including the Rwanda Cancer Center with radiotherapy, have reduced overseas treatment referrals.
• Progress noted in human papillomavirus (HPV) and hepatitis B vaccination, alongside increasing palliative care services.

Conclusions:

• Rwanda demonstrates substantial progress in cancer control, marked by policy development and improved treatment access.
• Key challenges persist, including enhancing public cancer awareness for early diagnosis, building a skilled cancer care workforce through in-country training, and expanding research capacity.